A series of studies by Marks and colleagues13,41–43 have shown that FKBP12.6 mediates cardiac arrhythmia, heart failure, and sudden cardiac death, which are attributed to dysfunction of the mechanism of RyR2 inhibition by FKBP12.6. This evidence concerns the gene FKBP1B and cardiac rhythm disease.